OBJECTIVES: The difference in the outcomes of nosocomial bloodstream infection (BSI) caused by community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strains and healthcare-associated MRSA (HA-MRSA) strains remains unclear. METHODS: From January 1, 2006 to December 31, 2008, all adult patients hospitalized at National Taiwan University Hospital with nosocomial MRSA BSI were analyzed. Available MRSA isolates were submitted for subsequent microbiologic studies to determine whether they belonged to CA-MRSA strains. RESULTS: In total, 308 patients were enrolled and 253 MRSA isolates were available. Forty-seven isolates belonged to CA-MRSA strains. The all-cause mortality rates on Day 14 and Day 30 were 19.8% and 30.5%, respectively, and were not different between those caused by CA-MRSA and HA-MRSA strains. The independent risk factors for Day 14 mortality were septic shock, thrombocytopenia, and an inadequate serum trough level of vancomycin (p = <0.0001, 0.0003, and 0.0381, respectively). Those for Day 30 mortality were septic shock, anemia, thrombocytopenia, presence of underlying malignancies, and MRSA isolates with a vancomycin minimum inhibitory concentration of 2 mg/L (p = <0.0001, 0.0425, 0.0007, 0.0098, and 0.0012, respectively). CONCLUSIONS: The mortality rates of nosocomial MRSA BSI were not different between that caused by CA-MRSA and HA-MRSA strains.
OBJECTIVES: The difference in the outcomes of nosocomial bloodstream infection (BSI) caused by community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strains and healthcare-associated MRSA (HA-MRSA) strains remains unclear. METHODS: From January 1, 2006 to December 31, 2008, all adult patients hospitalized at National Taiwan University Hospital with nosocomial MRSA BSI were analyzed. Available MRSA isolates were submitted for subsequent microbiologic studies to determine whether they belonged to CA-MRSA strains. RESULTS: In total, 308 patients were enrolled and 253 MRSA isolates were available. Forty-seven isolates belonged to CA-MRSA strains. The all-cause mortality rates on Day 14 and Day 30 were 19.8% and 30.5%, respectively, and were not different between those caused by CA-MRSA and HA-MRSA strains. The independent risk factors for Day 14 mortality were septic shock, thrombocytopenia, and an inadequate serum trough level of vancomycin (p = <0.0001, 0.0003, and 0.0381, respectively). Those for Day 30 mortality were septic shock, anemia, thrombocytopenia, presence of underlying malignancies, and MRSA isolates with a vancomycin minimum inhibitory concentration of 2 mg/L (p = <0.0001, 0.0425, 0.0007, 0.0098, and 0.0012, respectively). CONCLUSIONS: The mortality rates of nosocomial MRSA BSI were not different between that caused by CA-MRSA and HA-MRSA strains.
Authors: Bich Ngoc Thi Vu; Alexander J Jafari; Matthew Aardema; Huong Kieu Thi Tran; Diep Ngoc Thi Nguyen; Trinh Tuyet Dao; Trung Vu Nguyen; Toan Khanh Tran; Chuc Kim Thi Nguyen; Annette Fox; Anne-Laure Bañuls; Guy Thwaites; Kinh Van Nguyen; Heiman F L Wertheim Journal: J Med Microbiol Date: 2016-01-12 Impact factor: 2.472
Authors: Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell Journal: Clin Microbiol Rev Date: 2012-04 Impact factor: 26.132
Authors: S J Eells; J A McKinnell; A A Wang; N L Green; D Whang; P O'Hara; M L Brown; L G Miller Journal: Epidemiol Infect Date: 2012-12-06 Impact factor: 2.451
Authors: Warren E Rose; Sanjay K Shukla; Andrew D Berti; Mary S Hayney; Kelsey M Henriquez; Andrea Ranzoni; Matthew A Cooper; Richard A Proctor; Victor Nizet; George Sakoulas Journal: Clin Infect Dis Date: 2017-05-15 Impact factor: 9.079
Authors: Jon P Furuno; Jennifer K Johnson; Marin L Schweizer; Anayochukwu Uche; Oscar C Stine; Simone M Shurland; Graeme N Forrest Journal: BMC Infect Dis Date: 2011-10-31 Impact factor: 3.090